Isoflurane Vasodilation
Isoflurane Vasodilation - Related Videos
07:46
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
0 Views •
Cited by 165 •
2010
A noninvasive procedure to assess endothelial function is demonstrated using the Endo-PAT 2000.
08:09
Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
0 Views •
Cited by 1 •
2017
We describe the isolation of cardiac extracellular matrix from C57Bl/6J control mice, tight-skin mice, and tight-skin mice treated with the IRF5 inhibitory peptide. We also describe the vasodilation studies on the isolated vessels from C57Bl/6J, tight-skin mice and tight-skin mice treated with the IRF5 inhibitory peptide.
01:23
Antihypertensive Drugs: Vasodilators
0 Views •
2024
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
08:42
Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
0 Views •
Cited by 42 •
2014
Endothelial dysfunction is associated with numerous disease states and is predictive of adverse cardiovascular events in humans. Flow-mediated vasodilation (FMD) is a non-invasive ultrasound method of evaluating endothelial function. Methodological choices and operator experience may affect results. A systematic approach to FMD in human studies is discussed here.
08:22
Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
0 Views •
Cited by 4 •
2017
Insulin-induced vasodilation regulates muscle perfusion and increases the microvascular surface area (microvascular recruitment) available for solute exchange between blood and tissue interstitium. Combined intravital microscopy and contrast-enhanced ultrasonography is presented to simultaneously assess insulin's action at the larger vessels and the microcirculation in vivo.
FAQs
The response increases with anesthetic dose: as isoflurane exposure rises, vascular tone falls further, lowering systemic vascular resistance and potentially arterial pressure. This dose dependence means the cardiovascular effect is not fixed during an anesthetic. Changes in anesthetic depth should therefore be considered when interpreting blood-pressure changes and deciding whether supportive adjustments are needed.
At the cellular level, isoflurane acts on vascular smooth muscle by reducing contractile signaling and limiting calcium-dependent contraction. Because calcium-dependent contraction helps maintain smooth-muscle tone, weakening this pathway promotes relaxation. This mechanism links the drug’s molecular action to reduced vascular resistance, rather than treating the blood-pressure response as an isolated or unexplained anesthetic effect.
Vessel relaxation may improve tissue perfusion in some settings by reducing vascular tone, but the same response can become clinically problematic when it substantially lowers arterial pressure. The important issue is balance: improved flow to tissues is not assured if hypotension develops. Clinicians must therefore interpret perfusion and blood-pressure effects together rather than considering vasodilation beneficial or harmful in every case.
Arterial blood pressure requires attention because isoflurane-related relaxation can reduce systemic vascular resistance and produce hypotension. Monitoring helps clinicians recognize when the vascular response has become substantial enough to affect cardiovascular stability. The observed pressure change should be considered alongside anesthetic depth, since the vasodilatory effect varies with dose.
Management involves considering three interacting responses: the depth of isoflurane anesthesia, the degree of vasodilation, and the patient’s blood pressure. Clinicians may need to adjust anesthetic depth, address fluid management, or use vasoactive support when hypotension develops. The appropriate balance depends on the observed cardiovascular effect and the need to maintain adequate tissue perfusion.
The effect is particularly relevant during surgery and in critical care, where anesthetic exposure and cardiovascular stability must be managed together. Understanding the underlying vascular response helps clinicians anticipate reductions in vascular resistance, recognize hypotension, and select supportive strategies involving anesthetic depth, fluids, or vasoactive treatment while evaluating the patient’s perfusion.